TRANSCODE THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 28 May 2025)
What this means for you
Not registered yet, but its 20 Oct 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97083236
- Mark type
- Stylized text
- Filed
- 20 Oct 2021
- Published for opposition
- 04 Apr 2023
- Attorney of record
- Rosie Norwood-Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer; diagnostic preparations for medical purposes
Owner
- TransCode Therapeutics, Inc., Boston, MA, US
- TransCode Therapeutics, Inc., Boston, MA, US
Prosecution history
- 13 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Nov 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 4 GRANTED
- 28 May 2025 — SOU EXTENSION 4 FILED
- 28 May 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Oct 2024 — SOU EXTENSION 3 GRANTED
- 08 Oct 2024 — SOU EXTENSION 3 FILED
- 08 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 17 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2024 — SOU EXTENSION 2 GRANTED